Suzhou Highfine Biotech Co (SZSE:301393) 3-Year EBITDA Growth Rate : 25.00% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Suzhou Highfine Biotech Co 3-Year EBITDA Growth Rate?

Suzhou Highfine Biotech Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.32.

During the past 12 months, Suzhou Highfine Biotech Co's average EBITDA Per Share Growth Rate was -43.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 25.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 26.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Suzhou Highfine Biotech Co was 43.80% per year. The lowest was 25.00% per year. And the median was 33.90% per year.

Competitive Comparison of Suzhou Highfine Biotech Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Suzhou Highfine Biotech Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Suzhou Highfine Biotech Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suzhou Highfine Biotech Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Suzhou Highfine Biotech Co's 3-Year EBITDA Growth Rate falls into.

Suzhou Highfine Biotech Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Suzhou Highfine Biotech Co (SZSE:301393) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Suzhou Highfine Biotech Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Suzhou Highfine Biotech Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Highfine Biotech Co (SZSE:301393) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 32 Hongxi Road, F-12 Standard Factory Building, High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151

Website

https://www.highfine.com

Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.

Suzhou Highfine Biotech Co (SZSE:301393) Headlines

No Headlines